We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Maternal Exposure to Microplastics and High-Fructose Diet Induces Offspring Hypertension via Disruption of H2S Signaling, Gut Microbiota, and Metabolic Networks
Summary
Researchers found that maternal exposure to both microplastics and a high-fructose diet during pregnancy and lactation raised blood pressure in rat offspring, with additive effects when the two exposures were combined. Microplastic exposure suppressed hydrogen sulfide signaling enzymes in the kidneys and altered gut microbial communities linked to blood pressure regulation. The study suggests that prenatal microplastic exposure may program long-term cardiovascular and kidney risks in offspring through disrupted metabolic pathways.
Maternal consumption of a high-fructose (HF) diet or exposure to microplastics (MPs) can each independently affect kidney development and increase the risk of hypertension in adult offspring, yet their combined impact remains poorly understood. Dysregulation of hydrogen sulfide (H<sub>2</sub>S) signaling and alterations in gut microbiota are potential mediators of this programming. Pregnant rats received either standard chow or a 60% HF diet, with half of each group additionally exposed to sulfate-modified MPs (1 mg/L) with a 5 μm diameter throughout pregnancy and lactation. Male offspring were divided into four groups (n = 7-8 per group): control, HF, MP, and HF+MP. Maternal HF or MP exposure raised offspring blood pressure (BP), with additive effects when combined, and MP exposure caused renal injury. MP treatment also suppressed renal H<sub>2</sub>S-generating enzymes and reduced H<sub>2</sub>S production. Both HF and MP exposures altered gut microbial composition linked to BP regulation and induced metabolic changes in taurine/hypotaurine and sulfur pathways, suggesting impaired H<sub>2</sub>S production. These results indicate that maternal HF and MP exposures interfere with H<sub>2</sub>S signaling, gut microbiota, and metabolic programming, highlighting the H<sub>2</sub>S signaling as a potential target to reduce long-term kidney and cardiometabolic risks.
Sign in to start a discussion.